rs387906711
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_013444.4(UBQLN2):c.1516C>A(p.Pro506Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_013444.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 15 Pathogenic:2
- -
This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 506 of the UBQLN2 protein (p.Pro506Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 21857683). ClinVar contains an entry for this variant (Variation ID: 29952). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change affects UBQLN2 function (PMID: 21857683, 25616961, 26075709, 26152284, 27477512, 27834214, 30333186). This variant disrupts the p.Pro506 amino acid residue in UBQLN2. Other variant(s) that disrupt this residue have been observed in individuals with UBQLN2-related conditions (PMID: 23138764, 28716533), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at